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Overexpression of HSP-72 confers cytoprotection in experi-
mental peritoneal dialysis.
Background. Peritoneal dialysis is complicated by mesothe-
lial cell injury due to low biocompatibility of peritoneal dialysis
fluid (PDF). We have previously demonstrated that heat shock
protein (HSP)-72 is potently up-regulated in response to PDF
exposure of mesothelial cells in in vitro and in vivo models of
peritoneal dialysis. The aim of this study was to evaluate poten-
tial cytoprotective effects of overexpression of HSP-72.
Methods. Cytoprotection was assessed by comparing cellu-
lar viability between pretreated versus nonpretreated human
mesothelial cells (Met 5a; ATCC, Manassas, VA, USA, and pri-
mary cell cultures) subjected to extended, usually lethal PDF
exposure times (120 min, CAPD2; Fresenius, Bad Homburg,
Germany). Pretreatment was performed with exposure to PDF
(60 min, CAPD2; Fresenius) or heat (15 min, 41.5◦C), and by
transient transfection with HSP-72.
Results. When mesothelial cells were pretreated by nonlethal
exposure to PDF or heat, HSP-72 was markedly up-regulated
(>5-fold, P < 0.01). Pretreated human mesothelial cells were
significantly protected against subsequent “lethal” exposures to
PDF, as assessed by dye exclusion (>50% reduction, P < 0.05)
and lactate dehydrogenase (LDH) release (>30% reduction,
P < 0.05). Comparable cytoprotection (50% reduction by dye
exclusion) was indicated by overexpression of HSP-72 in cul-
tered human mesothelial cells (>5-fold) after transient trans-
fection with HSP-72. This cytoprotection was confirmed at a
cellular basis by double staining techniques with HSP-72 and
ApopTag (apoptosis detection kit).
Conclusion. Our study therefore shows that the mesothe-
lial stress response confers cytoprotection in experimental peri-
toneal dialysis, mediated by the induction of HSP-72, and that
the stimulus of the pretreatment does not have to be identi-
cal to the subsequent injury. These data offer the basis for an
attractive novel therapeutic approach against PDF toxicity.
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Peritoneal dialysis is a frequently used mode of renal
replacement therapy in end-stage renal disease (ESRD).
Using the peritoneum as a dialysis membrane, peritoneal
dialysis fluid (PDF) is filled and drained repeatedly to
and from the abdominal cavity. Based on its composition,
PDF thereby removes solutes and water from the uremic
patient. However, the physicochemical properties of PDF
have also been identified to contribute to considerable
cytotoxicity [1, 2]. In vitro, several studies have demon-
strated marked cytotoxic effects of acute PDF exposure
on human mesothelial cells.
Much shorter exposure times than used in clinical set-
ting result in severe and, depending on the exposure
times, lethal cellular injury as assessed by cell viability as-
says. In contrast, in vivo exposure to PDF seems well tol-
erated in clinical setting [3]. Only long-term exposure to
PDF (or complications such as peritonitis) results in clin-
ical relevant mesothelial damage and technical failure.
In attempts to explain this apparent discrepancy, most
investigators have focused on the rapid attenuation of
PDF cytotoxicity during the in vivo dwell [4].
However, increasing evidence suggests that stressors
such as PDF may not only result in cellular injury, but
also activate endogenous machinery found in every cell,
the so-called stress response [5, 6]. This stress response
includes cellular mechanisms that facilitate cellular re-
pair and survival after acute injury. Main effectors of this
stress response are the heat-shock proteins (HSP). In pre-
vious work, we described distinct roles for HSP in various
aspects of repair and cytoprotection against nonlethal in-
jury in different kinds of epithelial cells [7–10]. Most HSPs
are molecular chaperones, stabilizing protein molecules
under heat shock conditions in vitro and in vivo, and the
same chaperone activity may protect HSP-enriched cells
in the case of other proteotoxic stresses. Recently, we
have also described the induction of specific HSP iso-
forms in mesothelial cells exposed to PDF with and with-
out modification of its physicochemical properties (such
as pH and GDP content) in in vitro and in vivo systems;
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however, the functional relevance of HSP induction in
mesothelial cells remains unresolved [11–14].
This issue was addressed in the present study. We hy-
pothesized that excess HSP-72 in stress preconditioned
or HSP-72 overexpressing cells can preserve cellular via-
bility from the proteotoxic effects of usually lethal expo-
sure to PDF in a human mesothelial cell culture model of
peritoneal dialysis.
METHODS
Cell culture
Human peritoneal mesothelial cells were isolated from
specimens of omentum obtained from nonuremic pa-
tients (N = 3) undergoing elective abdominal surgery
and characterized as described in detail elsewhere [15].
The purity of mesothelial cell culture was assessed by
staining for cytokeratin (positive) and factor VIII (neg-
ative). Cells were plated in multiwell clusters (Saarstedt,
Inc., Newton, NC, USA) and propagated in M199 culture
medium supplemented with L-glutamine (2 mmol/L),
penicillin (100 U/mL), streptomycin (100 mg/mL), hydro-
cortisone (0.4 mg/mL), and 10% v/v fetal calf serum (FCS;
Gibco BRL, Life Technologies, Eggenstein, Germany)
until confluence. The standard medium containing 10%
FCS was replaced with medium supplemented with 0.1%
FCS 48 hours before experiment in order to render cells
quiescent. Experiments were performed using cells from
the first 3 passages because later subcultures contained
increasing number of senescent cells.
Immortalized human mesothelial cells (Met5A, CRL-
9444; ATCC, Manassas, VA, USA) were maintained un-
der standard conditions, as described previously [16],
in M199/MCDB 105 medium (1:1) supplemented with
5 ng/mL epidermal growth factor (EGF), 0.4 mg/mL
hydrocortisone, 0.05 mg/mL gentamycin and 10% FCS.
Cultures were kept in 75-mm plastic dishes (Falcon, BD
Bioscience, Franklin Lakes, NJ, USA) or in 48-well plates
(Falcon, BD Bioscience) at 37◦C in a 5% CO2 humid-
ified incubator, and passaged by regular trypsinization.
Medium was changed every 2 days, and confluence was
reached on average after 3 to 4 days. Cells for use in im-
munofluorescence staining were grown on microscopic
slides (Culture Slides; Falcon, BD Bioscience), using the
same medium and atmosphere as mentioned previously.
PDF incubation
As previously described, confluent cultures were ex-
posed to commercially available glucose-monomer and
acidic lactate-based PDF (CAPD2; Fresenius Medical
Care, Bad Homburg, Germany), containing 1.5% anhy-
drous dextrose at pH 5.5, for various durations from usu-
ally nonlethal (30 and 60 min), increasing to lethal PDF
exposure (120 and 240 min), and were then allowed to
Day 1
Day 2
Day 3 Con LT PT+LT PT
Viability assessment − cytoprotection?
Lethal treatment
No pretreatment Nonlethal
pretreatment
Fig. 1. Scheme of the cytoprotection assay. Human mesothelial cell
cultures at confluence either underwent sham media changes (no pre-
treatment) or nonlethal stress by PDF or heat pretreatment (PT). The
next day, nonpretreated and PT cells were either subjected to sham me-
dia changes or lethal PDF exposure (LT). Mesothelial cell cultures from
the resulting 4 treatment groups (Con, LT, PT+LT, PT) were compared
at appropriate recovery times for HSP expression or cellular viability,
as described in the Methods section.
recover in regular growth medium for 24 hours [11–13].
Control cultures were kept in regular culture media at
37◦C in 5% CO2 atmosphere, and underwent identical
“sham-procedures” of media changes (i.e., exposure to
PDF was paralleled by exposure to control medium for
the times indicated). At the end of the recovery period,
induction of HSP-72 and cell viability was assessed in par-
allel cultures as described below.
Cytoprotection assay
Confluent mesothelial cells were either subjected
to “sham” culture changes (no pretreatment) or to
60-minute nonlethal PDF exposure (nonlethal pretreat-
ment) as described above, or were heated in a warm wa-
ter bath. Because hyperthermia at 41.5◦C for 30 minutes
resulted in marked HSP-72 induction without reduced
cellular viability at 24 hours’ recovery, these conditions
were chosen as nonlethal heat shock pretreatment (“cross
tolerance induction”) (see Fig. 1).
Transfection procedures
Cells are grown until 60% to 70% confluence on the day
of transfection. HSP-72 cDNA (a kind gift from Profes-
sor Michael Kashgarian and his laboratory, Department
of Medicine, Pathology, Yale University) was dissolved
in TE buffer pH 7 to pH 8 to a minimum DNA concen-
tration of 0.1 lg/lL with cell growth medium containing
no antibiotics.
An adequate amount of PolyFect Transfection Reagent
(Qiagen, Valencia, CA, USA) is added to the DNA so-
lution at room temperature for up to 10 minutes to al-
low complex formation. While complex formation takes
place, cells are washed once with phosphate-buffered
saline (PBS).
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Cell growth medium is added to the reaction tube
containing the transfection complexes. The appropriate
amount of growth media containing transfection com-
plexes was immediately transferred to the cells in the
dishes. Cells are then incubated for 24 hours at 37◦C and
5% CO2 to allow gene expression.
After 24-hour recovery in regular culture medium at
37◦C in 5% CO2 atmosphere, cells were either subjected
to “lethal treatment” with usually lethal PDF exposure
(120 min), or underwent mere “sham” culture change.
At the end of the protocol, cell viability was either then
(vital dye exclusion), or after additional 24 hours in cul-
ture media at 37◦C in 5% CO2 atmosphere LDH release
assessed as described below.
Viability parameters
Dead cells were identified by incapability of standard
vital dye exclusion. For statistic analysis, cells from inde-
pendent experiments were stained with Trypan blue for
15 minutes, and evaluated in a hemocytometer chamber.
Cells capable of dye exclusion (viable) and cells stained
with Trypan blue (nonviable) were counted, and percent
viability calculated. In separate experiments, cells were
grown on microscopic chamber slides and stained suprav-
ital with propidium iodide (PI). After the described
experimental setup PI (30 lmol/L; Molecular Probes,
Eugene, OR, USA) was added to stain damaged cells for
20 minutes at 37◦C. The chamber slides were washed in
PBS, and cells were fixed in 4% paraformaldehyde in PBS
pH 7.4 for 20 minutes at room temperature. The fixative
was washed away, and slides were mounted with Mowiol
(Calbiochem, San Diego, CA, USA). Slides were viewed
on an Olympus BX60 microscope equipped for epifluo-
rescence at an excitation wavelength of 546 nm (40-nm
band pass) and an emission wavelength of 620 nm (50-
nm band pass). Images were collected with a color digital
camera (MagnaFire, Optronics, Goleta, CA, USA). For
LDH analyses, 50 lL aliquots of supernatants were re-
moved 24 hours after the described experimental setup,
and kept on 4◦C until analyzed within 48 hours. Measure-
ments were performed in duplicates with Sigma TOX-7
LDH Kit according to the manufacturer’s instructions.
LDH efflux was calculated as percentage of LDH values
measured in each negative control experiment.
Immunofluorescence staining
Optimal primary and secondary antibody incubation
concentrations and conditions were previously deter-
mined and based on recommendations in the literature.
According to the experimental setup, after the incuba-
tion experiments, cells were washed 2 times with PBS,
and fixed with 4% paraformaldehyde in PBS pH 7.4 for
20 minutes at room temperature. Cells were then perme-
abilized for 20 minutes with either 0.1% Triton X-100 or
0.1% Saponin in PBS (pH 7.4). Nonspecific binding sites
were blocked for 45 minutes in 5% FCS and 1% bovine
serum albumin (BSA) in PBS (pH7.4). HSP72 was im-
munodetected by sequential incubation with monoclonal
anti-HSP72 antibody (SPA810, 1:300 in PBS containing
1% BSA and 0.1% Saponin; Stressgen, Victoria, British
Columbia, Canada).
Immunofluorescence staining and double labeling with
ApopTag
In separate experiments, primary human mesothelial
cells were grown on microscopic chamber slides, and
stained by using the ApopTag Red in situ Apoptosis
Detection Kit (Chemicon International, Temecula, CA,
USA) by indirect immunofluorescent staining, according
to the manufacturer’s instructions. Thereby, 3′-OH ends
of the DNA fragments are labeled with nucleotides mod-
ified with digoxigenin. The digoxigenin is recognized by
a sulforhodamine-conjugated anti-digoxigenin antibody.
Thus, apoptotic cells in culture can be detected. Cells
then underwent regular immunofluorescence staining for
HSP-72 as mentioned above. Primary and secondary an-
tibodies were used in PBS only. Images were collected
with a color digital camera (MagnaFire, Optronics). Im-
ages were stored and analyzed using Olympus Image An-
alyzing Software (MagnaFire, Optronics).
Western blotting
At the end of the recovery period, cells were washed
twice in PBS and lysed in buffer containing 0.1% Tri-
ton X-100, 60 mmol/L PIPES, 2 mmol/L CDTA, 1
mmol/L EDTA, 1 mmol/L EGTA, 100 mmol/L NaCl, 0.5
mmol/L PMSF, and 0.75 mg/L leupeptin. Protein con-
tent was determined by Bradford assay (BioRad, Her-
cules, CA, USA), and equal amounts of protein samples
(5 lg/lane) were separated by standard sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
using a Pharmacia Multiphore II unit (Uppsala, Sweden).
Size-fractionated proteins were transferred to polyvinyli-
dene fluoride (PVDF) membranes by semidry transfer in
a Pharmacia Multiphore II Novablot unit. Membranes
were blocked in 5% dry milk in TBS-Tween (10 mmol/L
Tris, 150 mmol/L NaCl, 0.05% Tween 20, pH 8.0). Mem-
branes were incubated with the primary antibody against
HSP-72 (SPA 810; Stressgen) or actin (Sigma Chemical
Company, St. Louis, MO, USA). Detection was accom-
plished by incubation with secondary peroxidase-coupled
antibodies (Sigma Chemical Company) and enhanced
chemiluminescence (ECL) using ECL Western blotting
analysis system and protocols (Renaissance; NEN-Life
Science Products, Boston, MA, USA).
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Fig. 2. Cytoprotection in cultured human mesothelial cells pretreated by nonlethal PDF exposure. Immunofluorescence staining for HSP-72 is
shown in the upper panel: nonpretreated cultures (right upper panel) and cultures pretreated by PDF for 60 minutes (PT) and allowed to recover
for 24 hours (left upper panel). Fluorescence staining for propidium iodide (PI) after lethal treatment (lower panel) is shown in cells exposed to
sham treatment (Con) or to usually lethal PDF exposure (LT, PT, PT+LT). Nonlethal PDF pretreatment resulted in marked HSP-72 induction and
protection of cellular viability (PT+LT). Data are representative for 3 independent experiments.
Statistical analysis
Each experiment was performed at least in inde-
pendent triplicates. Where appropriate, different groups
were compared using a two-tailed Student t test or
Wilcoxon signed rank test (version 7.5 for Windows;
SPSS, Inc. Chicago, IL, USA). Values for each treatment
condition were compared to control values, and differ-
ences were considered to be significant given when P <
0.05. The data are expressed as mean ± SD of at least 3
separate experiments.
RESULTS
In order to assess eventual cytoprotective effects of
mesothelial HSP overexpression, we designed an in vitro
cytoprotection assay. First, we analyzed the effects of
varying the exposure times to PDF on HSP-72 expres-
sion in cultured human mesothelial cells, and correlated
these results to cell viability obtained at 24 hours’ re-
covery. Increasing the exposure times from 30 minutes
to 60 minutes resulted in progressively increased HSP-
72 expression levels (143% vs. 560% of controls, both
P < 0.05 vs. controls). This coincided with full recovery
in terms of cell viability. In contrast, exposure to PDF for
120 minutes resulted in significantly reduced cell viabil-
ity (68 ± 16% of control for dye exclusion; 242 ± 26%
of controls for LDH release, both P < 0.05 vs. controls),
but failed to further increase HSP-72 protein expression
(470% of controls, P < 0.05).
Because exposure to PDF for 60 minutes resulted in
marked HSP-72 induction without reduced cellular via-
bility after 24 hours’ recovery, the cytoprotective effects
of such a nonlethal pretreatment (“classic conditioning”)
were assessed as schematized in Figure 1.
Results of this cytoprotection assay are demonstrated
in Figure 2. After exposure to PDF, cultured human
mesothelial cells exhibited a strong cytoplasmic staining
pattern for HSP-72. Only few untreated cells (control)
expressed HSP-72.
This overexpression of HSP-72 was associated with
marked cytoprotection in the pretreated mesothelial cell
cultures as evaluated by PI staining. Only few mesothelial
cells were fluorescent after sham treatment, but a signif-
icant amount of cells became positive after 120-minutes
exposure to PDF. Whereas fluorescence in pretreated cell
cultures was similar to control, the pretreated cultures
demonstrated a markedly reduced fluorescence after
120-minute exposure to PDF compared to the nonpre-
treated cell cultures.
In order to quantify and confirm the relative role of the
mesothelial stress response, we compared cytoprotection
conferred by 2 nonrelated stressful stimuli: PDF exposure
(the combination between acidosis, hyperosmolarity, and
other, yet undefined, toxicity) versus heat shock (the gold
standard of inducers of the cellular stress response). As
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Fig. 3. Quantification of cytoprotection conferred by two different
conditioning protocols in human mesothelial cells. After lethal PDF
exposure, LDH release was compared between nonpretreated cultures
and cultures pretreated (PT) either with PDF (upper panel) or heat
shock (lower panel). Compared with nonpretreated cells (LT), LDH
release was significantly reduced in cells with prior nonlethal pretreat-
ment (PT+LT). There was no effect on LDH release by the pretreat-
ment alone (PT). Cytoprotective effects were similar with both stressful
stimuli. Data are derived from 9 to 12 independent experiments.
shown in Figure 3, conditioned mesothelial cell cultures
were significantly more resistant against usually lethal
PDF exposure, regardless of the stressful stimuli used in
the pretreatment protocol (”cross tolerance induction”).
Vital Dye staining was reduced from 37% to 14% (P <
0.05) with PDF pretreatment [and to 17% (P < 0.05) with
heat pretreatment], and LDH release was reduced from
242% to 153% (P < 0.05) with PDF pretreatment [and
to 146% (P < 0.05) with heat pretreatment]. Neither pre-
treatment alone had effects on these markers of cellular
viability at 24 hours’ recovery from injury.
Finally, in order to assess the specific role of HSP-72
overexpression, we evaluated cytoprotection in mesothe-
lial cells exposed to PDF after they were either trans-
fected with HSP-72 or bare vector. HSP-72 transfection
resulted in a 5.07-fold increase of HSP-72 expression at
the time of PDF exposure 24 hours after the transfection
protocol (Fig. 4). Neither transfection with HSP-72 nor
with the vector had a direct effect on mesothelial viabil-
ity. As shown in Figure 5, viability parameters such as
Vital Dye exclusion were significantly preserved in cul-
tures pretreated by HSP-72 transfection. Vital Dye stain-
ing was reduced from 88.6% (STD 11.2) to 44.7% (STD
36.78) (P < 0.05) with this gene therapeutic approach.
In an additional experiment in primary human peri-
toneal mesothelial cell cultures (Fig. 6) using double la-
beling techniques for HSP-72 and ApopTag, we could
demonstrate that HSP-72 staining after transfection
and PDF exposure was particularly prevalent in vital
mesothelial cells (ApopTag negative), whereas ApopTag
staining was exclusively found in HSP-72–negative cells.
This lack of colocalization directly confirmed HSP-72–
mediated cytoprotection at a cellular basis.
DISCUSSION
This study clearly demonstrates that repeat exposure of
the peritoneum to PDF, as is the case in clinical peritoneal
dialysis, not only causes repeat injury to mesothelial cells,
but also induces protective cellular mechanisms, such as
the overexpression of HSP-72.
In peritoneal dialysis, the final cellular outcome de-
pends on the balance between continuing injury and
ongoing repair processes [17]. There is clear evidence
demonstrating that cytotoxicity of PDF is a major cause of
mesothelial injury [1, 2]. More recently, we have demon-
strated that the same cytotoxic properties of PDF also
strongly induce HSP in in vivo and in vitro models of
peritoneal dialysis [11–14].
What is the role of HSP-72 expression in mesothe-
lial cells after PDF exposure? Whereas previous stud-
ies focused on the up-regulation of HSP expression as
a marker of biocompatibility of PDF, so far there are no
data about their potential effects on cellular repair in peri-
toneal dialysis [11–14, 17–19]. In other models, however,
induction of HSP is currently less regarded as a marker
for cellular injury, but rather as an indicator for essential
cellular mechanisms that facilitates repair and survival
after such injury [5–10]. Moreover, increasing evidence
suggests that overexpression of HSP and/or activation
of the cellular stress response might also confer protec-
tion against repeat injury [5, 6, 20]. Organisms and tissues
which overexpress HSP have been shown to be more re-
sistant, and those whose HSP expression is suppressed to
be more sensitive to cellular injury. Similarly, pretreat-
ment with a nonlethal dose of cellular stress resulted in
survival of a subsequent, usually lethal, dose of the same
or other injury [20–22]. These findings of increased re-
sistance to repeat cellular injury are called cytoprotec-
tion, and the treatment resulting in this cytoprotection is
termed “conditioning.” To assess the question of a po-
tential functional role of HSP-72 in human mesothelial
cells, we hypothesized that cytoprotection is conferred by
HSP-72, and therefore, evaluated such “conditioning” in
a strictly controlled in vitro system of experimental peri-
toneal dialysis.
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Fig. 4. Transfection with HSP-72 or bare vector. HSP-72 expression after transfection with control (A), bare vector (B), or HSP-72 (C) shown by
immunofluorescent staining and on protein level. HSC staining is shown for loading control.
Our results clearly demonstrate that nonlethal pre-
treatment by the same stressor (“classical conditioning”)
confer strong cytoprotective effects. Conditioned human
mesothelial cells, subjected to repeat exposure to PDF
at an intensity which would usually result in lethal injury,
showed significantly preserved viability compared to non-
pretreated mesothelial cell cultures. Interestingly, our re-
sults suggest that peritoneal dialysis includes aspects of
in vivo preconditioning in itself, as the therapeutic prin-
ciple is repeated exposure to PDF several times a day.
Although this hypothesis must be verified in the animal
model, it represents an attractive alternate explanation to
the apparent higher resistance of mesothelial cells to PDF
in vivo than in vitro. These data also corroborate well with
the previously reported finding of increased staining for
HSP-72 in peritoneal biopsies of patients on complicated
peritoneal dialysis [18].
Although this cytoprotection was strongly associated
with mesothelial overexpression of HSP-72, other cellu-
lar processes, such as induction of specific tonicity respon-
sive mechanisms or stress-induced stress kinases, might
also have resulted in increased resistance against repeat
PDF exposure [23]. However, our finding that heat, as
for the physicochemical properties completely unrelated
stressor, also confers cytoprotection, a specific finding
called “cross tolerance,” suggests that these effects were
indeed mediated by the mesothelial stress response [24–
27]. In the present study, cells conditioned by nonlethal
heat pretreatment demonstrated similar preservation of
viability parameters against extended, usually lethal PDF
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Fig. 5. Quantification of cytoprotection after transfection with HSP-72
or bare vector. Viability assessed by Vital Dye exclusion after either ex-
posure to normal culture media or lethal PDF exposure for 120 minutes
compared between HSP-72–transfected cells and bare vector. Viability
is significantly preserved in cultures pretreated by HSP-72 transfection
(N = 24). HSP-72 transfection resulted in a marked increase of HSP-
72 expression at the time of PDF exposure compared to bare vector
transfection.
exposure, as obtained with nonlethal PDF pretreatment.
These results confirm that one or several of the complex
pathways induced by the cellular stress response are re-
sponsible for the observed cytoprotection.
In the second part of this study we aimed to specifically
dissect the role of HSP-72 in experimental peritoneal
dialysis. HSP-72, the major effector of the mammalian
stress response, is an extremely conserved molecular
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HSP-72 Apop Tag
Colocalization
Fig. 6. Double staining of HSP-72 trans-
fected cells. Immunofluorescentstaining for
HSP-72 (green) and for ApopTag (red) in pri-
mary human mesothelial cells. Overexpres-
sion of HSP-72 after transfection and PDF
exposure was particularly prevalent in vital
cells (ApopTag negative), whereas ApopTag
staining was exclusively found in HSP-72 neg-
ative cells, thus directly confirming HSP-72–
mediated cytoprotection at a cellular basis.
Data are representative for 3 independent ex-
periments.
chaperone, and known to bind to nascent, immature,
or disrupted proteins [5, 28]. This, in turn, prevents im-
proper folding of these proteins, and likely assists in
post-translational repair processes. As overall de novo
synthesis of proteins is known to be reduced in cells upon
exposure to PDF, such molecular recycling by chaper-
ones might be essential for mesothelial survival [1, 2, 5].
We therefore used well-established techniques of tran-
sient gene transfection to cause selective overexpression
of HSP-72 in human mesothelial cells before exposure to
PDF. Our results illustrated that overexpression of HSP-
72 significantly improves the outcome of mesothelial cells
upon exposure to PDF. These data are in good agreement
with other recent studies, which also demonstrated evi-
dence for HSP-72–mediated cytoprotection at conditions
that are known to result in similar ATP depletion as re-
ported after PDF exposure [22, 24, 29, 30].
Multiple cellular mechanism for HSP-mediated cyto-
protection have been described, including preservation
of cellular functions and structures, such as cell mem-
branes, mitochondrial energy metabolism, cytoskeletal
integrity, and prevention from apoptosis [28]. In this
study, we focused on the effects of the stress response (and
overexpression of HSP-72) on the viability of mesothe-
lial cells during experimental PD. Recent studies pro-
vided evidence that programmed cell death represents a
predominant form of mesothelial death during recovery
from exposure to PDF [31–34]. In contrast to receptor-
mediated apoptosis, the signal that leads to this stress-
induced active cell death somehow ‘detects’ that the
damage can no longer be contained by the cellular repair
mechanisms. The cellular stress response regulates this
balance between recovery and cell death; and HSP has
been shown to suppress several of the known cell death
signaling pathways [35, 36]. Although further studies are
needed to delineate the targets of HSP-72 in stressed
mesothelial cells (Apaf-1, caspases, JNK, NFkappaB, or
other mediators of oxidative stress induced by exposure
to glucose degradation products), our data on reduced
nick end labeling upon transfection with HSP-72 suggests
suppression of secondary programmed cell death as one
of the mechanisms of cytoprotection during recovery fol-
lowing PDF exposure [36–38].
CONCLUSION
Taken together, our study demonstrates that pretreat-
ment of cultured human mesothelial cells with nonlethal
exposure to PDF or heat not only induced strong over-
expression of HSP-72, but also conferred marked cyto-
protection against subsequent, usually lethal, exposure
to PDF. Similar mesothelial cytoprotection could be in-
duced by transient transfection of HSP-72 before expo-
sure to PDF. As pretreatment protocols based on PDF or
heat are neither very attractive nor feasible approaches in
the clinical setting of peritoneal dialysis, the effectiveness
of HSP-72 transfection provides the basis to study cyto-
protection as an attractive novel therapeutic approach in
future in vivo studies.
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